Study of Non-Small Cell Lung Cancer Patients in the US Receiving Standard-of-Care and Initiating an Approved Therapy with Risk of Pneumonitis/ILD - LOOP

Study identifier:D7680C00001

ClinicalTrials.gov identifier:NCT06192004

EudraCT identifier:N/A

CTIS identifier:N/A

Recruiting

Official Title

An Observational, Prospective, Multicenter Study of Non-Small Cell Lung Cancer Patients in the US Receiving Standard-of-Care and Initiating an Approved Therapy with Risk of Pneumonitis/ILD

Medical condition

Non-small Cell Lung Cancer

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Estimated Enrollment

600

Study type

Observational

Age

18 Years - n/a

Date

Study Start Date: 05 Jan 2024
Estimated Primary Completion Date: 03 Jun 2025
Estimated Study Completion Date: 03 Jun 2025

Study design

Allocation: Non-randomized
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Feb 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria